A Cell-Based High-Throughput Screening Assay to Measure Cellular Histone H3 Lys27 Trimethylation with a Modified Dissociation-Enhanced Lanthanide Fluorescent Immunoassay

Journal of Biomolecular Screening

Volumn 17, Issue 1, 2012, Pages 99-107

  Xie, Wensheng ^a   Ames, Robert S ^a   Li, Hu ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; HISTONE; HISTONE LYSINE METHYLTRANSFERASE; HISTONE METHYLTRANSFERASE; LANTHANIDE; LYSINE;

ARTICLE; CELL SURVIVAL; CHEMISTRY; DOSE RESPONSE; DRUG ANTAGONISM; ECONOMICS; FLUORESCENT ANTIBODY TECHNIQUE; HIGH THROUGHPUT SCREENING; HUMAN; ISOLATION AND PURIFICATION; MALE; METABOLISM; METHYLATION; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FLUORESCENT ANTIBODY TECHNIQUE; HIGH-THROUGHPUT SCREENING ASSAYS; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; HUMANS; LANTHANOID SERIES ELEMENTS; LYSINE; MALE; METHYLATION; PROSTATIC NEOPLASMS;

EID: 84862637665     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057111422378     Document Type: Article

References (23)

1. Kornberg R. D. Lorch Y. Twenty-Five Years of the Nucleosome, Fundamental Particle of the Eukaryote Chromosome. Cell 1999, 98, 285–294.
2. Luger K. Richmond T. J. The Histone Tails of the Nucleosome. Curr. Opin. Genet. Dev. 1998, 8, 140–146.
3. Jenuwein T. The Epigenetic Magic of Histone Lysine Methylation. FEBS J. 2006, 273, 3121–3135.
4. Roth S. Y. Allis C. D. Histone Acetylation and Chromatin Assembly: A Single Escort, Multiple Dances? Cell 1996, 87, 5–8.
5. Jenuwein T. Allis C. D. Translating the Histone Code. Science 2001, 293, 1074–1080.
6. Cao R. Zhang Y. The Functions of E(Z)/EZH2-Mediated Methylation of Lysine 27 in Histone H3. Curr. Opin. Genet. Dev. 2004, 14, 155–164.
7. Levine S. S. Weiss A. Erdjument-Bromage H. Shao Z. Tempst P. Kingston R. E. The Core of the Polycomb Repressive Complex Is Compositionally and Functionally Conserved in Flies and Humans. Mol. Cell Biol. 2002, 22, 6070–6078.
8. Shao Z. Raible F. Mollaaghababa R. Guyon J. R. Wu C. T. Bender W. Kingston R. E. Stabilization of Chromatin Structure by PRC1, a Polycomb Complex. Cell 1999, 98, 37–46.
9. Simon J. A. Kingston R. E. Mechanisms of Polycomb Gene Silencing: Knowns and Unknowns. Nat. Rev. Mol. Cell Biol. 2009, 10, 697–708.
10. Bernstein B. E. Mikkelsen T. S. Xie X. Kamal M. Huebert D. J. Cuff J. Fry B. Meissner A. Wernig M. Plath K. A Bivalent Chromatin Structure Marks Key Developmental Genes in Embryonic Stem Cells. Cell 2006, 125, 315–326.
11. Mikkelsen T. S. Ku M. Jaffe D. B. Issac B. Lieberman E. Giannoukos G. Alvarez P. Brockman W. Kim T. K. Koche R. P. Genome-Wide Maps of Chromatin State in Pluripotent and Lineage-Committed Cells. Nature 2007, 448, 553–560.
12. Karanikolas B. D. Figueiredo M. L. Wu L. Comprehensive Evaluation of the Role of EZH2 in the Growth, Invasion, and Aggression of a Panel of Prostate Cancer Cell Lines. Prostate 2010, 70, 675–688.
13. Kleer C. G. Cao Q. Varambally S. Shen R. Ota I. Tomlins S. A. Ghosh D. Sewalt R. G. Otte A. P. Hayes D. F. EZH2 Is a Marker of Aggressive Breast Cancer and Promotes Neoplastic Transformation of Breast Epithelial Cells. Proc. Natl. Acad. Sci. U. S. A. 2003, 100, 11606–11611.
14. Simon J. A. Lange C. A. Roles of the EZH2 Histone Methyltransferase in Cancer Epigenetics. Mutat. Res. 2008, 647, 21–29.
15. Sneeringer C. J. Scott M. P. Kuntz K. W. Knutson S. K. Pollock R. M. Richon V. M. Copeland R. A. Coordinated Activities of Wild-Type Plus Mutant EZH2 Drive Tumor-Associated Hypertrimethylation of Lysine 27 on Histone H3 (H3K27) in Human B-cell Lymphomas. Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 20980–20985.
16. Varambally S. Dhanasekaran S. M. Zhou M. Barrette T. R. Kumar-Sinha C. Sanda M. G. Ghosh D. Pienta K. J. Sewalt R. G. Otte A. P. The Polycomb Group Protein EZH2 Is Involved in Progression of Prostate Cancer. Nature 2002, 419, 624–629.
17. Kubicek S. O’Sullivan R. J. August E. M. Hickey E. R. Zhang Q. Teodoro M. L. Rea S. Mechtler K. Kowalski J. A. Homon C. A. Reversal of H3K9me2 by a Small-Molecule Inhibitor for the G9a Histone Methyltransferase. Mol. Cell 2007, 25, 473–481.
18. Cheng D. Yadav N. King R. W. Swanson M. S. Weinstein E. J. Bedford M. T. Small Molecule Regulators of Protein Arginine Methyltransferases. J. Biol. Chem. 2004, 279, 23892–23899.
19. Murray K. The Acid Extraction of Histones from Calf Thymus Deoxyribonucleoprotein. J. Mol. Biol. 1966, 15, 409–419.
20. Turlais F. Hardcastle A. Rowlands M. Newbatt Y. Bannister A. Kouzarides T. Workman P. Aherne G. W. High-Throughput Screening for Identification of Small Molecule Inhibitors of Histone Acetyltransferases Using Scintillating Microplates (FlashPlate). Anal. Biochem. 2001, 298, 62–68.
21. Kamei M. Kato M. Mochizuki K. Kuroda K. Sato S. Hashizume S. Yasumoto K. Murakami H. Nomoto K. Serodiagnosis of Cancers by ELISA of Anti–Histone H2B Antibody. Biotherapy 1992, 4, 17–22.
22. Miranda T. B. Cortez C. C. Yoo C. B. Liang G. Abe M. Kelly T. K. Marquez V. E. Jones P. A. DZNep Is a Global Histone Methylation Inhibitor That Reactivates Developmental Genes Not Silenced by DNA Methylation. Mol. Cancer Ther. 2009, 8, 1579–1588.
23. Hayden A. Johnson P. W. Packham G. Crabb S. J. S-Adenosylhomocysteine Hydrolase Inhibition by 3-Deazaneplanocin A Analogues Induces Anti-Cancer Effects in Breast Cancer Cell Lines and Synergy with Both Histone Deacetylase and HER2 Inhibition. Breast Cancer Res. Treat. 2011, 127, 109–119.